Pharmacological Intervention Using Reconstituted High-Density Lipoprotein Changes in the Lipid Profile in Spontaneously Hypersensitive Rats

By Imaizumi Satoshi   Kiya Yoshihiro   Miura Shin-Ichiro   Zhang Bo   Matsuo Yoshino   Uehara Yoshinari   Rye Kerry-Anne   Saku Keijiro  

Clinical and Experimental Hypertension, Vol. 32, Iss. 3, 2010-05 ,pp. : 202-208

Informa Healthcare

Access to resources Recommend Favorite

It's Time to Reassess the High‐Density Lipoprotein (HDL) Hypothesis: CSL112, a Novel Promising Reconstituted HDL Formulation

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Infusion of Reconstituted High‐Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Density Lipoprotein: A Novel Marker for Risk of In-Hospital Infection in Acute Ischemic Stroke Patients?

By  

Cerebrovascular Diseases, Vol. 35, Iss. 3, 2013-04 ,pp. : 291-297

Karger

Access to resources Recommend Favorite

Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies

By Aslibekyan Stella   Straka Robert J   Irvin Marguerite R   Claas Steven A   Arnett Donna K  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 3, 2013-03 ,pp. : 355-364

Informa Healthcare

Access to resources Recommend Favorite